Skip to content


You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patients

  • Eydis Th Gudmundsdottir1,
  • Rosa B Barkardottir1, 2,
  • Adalgeir Arason1, 2,
  • Haukur Gunnarsson1, 3,
  • Laufey Th Amundadottir4,
  • Bjarni A Agnarsson1, 2,
  • Oskar Th Johannsson2, 5 and
  • Inga Reynisdottir1Email author
BMC Cancer201212:621

Received: 15 October 2012

Accepted: 21 December 2012

Published: 27 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
15 Oct 2012 Submitted Original manuscript
27 Nov 2012 Reviewed Reviewer Report - Christina Justenhoven
4 Dec 2012 Reviewed Reviewer Report - Marc Tischkowitz
19 Dec 2012 Author responded Author comments - Inga Reynisdottir
Resubmission - Version 2
19 Dec 2012 Submitted Manuscript version 2
21 Dec 2012 Editorially accepted
27 Dec 2012 Article published 10.1186/1471-2407-12-621

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Department of Pathology, Landspitali-University Hospital
BMC, Faculty of Medicine, University of Iceland
Actavis, Hafnarfjordur
Department of Health and Human Services, Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
Department of Oncology, 20A, Landspitali-University Hospital